Insider · CIK 0001169337
Robert Alan Berman
Files at REKR (Rekor Systems, Inc.). First filing -, latest -.
In brief
Robert Alan Berman files SEC Form 4 as chair, director and CEO at REKR (Rekor Systems, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Robert Alan Berman has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 27, 2026 | REKR Rekor Systems, Inc. | GGift Common Stockindirect: By Avon Road, L.P. | -1,000,000 | - | - | 1,000 | May 29, 2026 |
| Apr 21, 2026 | REKR Rekor Systems, Inc. | AGrant or award Common Stock | +1,000,000 | $0.00 | $0 | 2,685,219 | Apr 28, 2026 |
| Dec 18, 2024 | REKR Rekor Systems, Inc. | GGift Common Stockindirect: By Avon Road, L.P. | -864,104 | - | - | 1,001,000 | Dec 20, 2024 |
Questions about Robert Alan Berman
Answered from the filings on this page, as of the latest one.
Is Robert Alan Berman buying or selling?
Robert Alan Berman has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Robert Alan Berman's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Robert Alan Berman has 0.
Where does Robert Alan Berman file Form 4?
Robert Alan Berman has filed Form 4 at REKR (Rekor Systems, Inc.) as CEO and Executive Chairman. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.